Observational Evaluation of Atopic Dermatitis in Pediatric Patients
Study Overview
Primary Objectives:
- To describe the characteristics of pediatric patients with moderate to severe atopic dermatitis (AD) whose disease is not adequately controlled with topical therapies or when those therapies are not medically advisable.
- To evaluate the time-course of AD and selected atopic comorbidities.
Secondary Objectives:
- To characterize disease burden and unmet need.
- To describe real-world treatment patterns (eg, dosing regimens, treatment duration, and reasons for discontinuation and/or switching).
- To document the real-world effectiveness and safety of treatments.
Study details
The study duration is 60 months.
Eligibility Criteria
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Dermatitis Atopic
-
Age: - 11 Years
-
Gender: All
Inclusion criteria:
- Patients with moderate to severe AD, according to the Investigator's assessment;
- Currently receiving systemic treatment (including phototherapy) for atopic dermatitis or currently on topical treatment, but otherwise candidates for systemic treatment.
Exclusion criteria:
- Concurrent participation in an interventional clinical trial which modifies patient care.
The above information is not intended to contain all considerations relevant to a patient's
potential participation in a clinical trial.
Updated on
27 Mar 2024.
Study ID: NCT03687359
Find a Study Location to Connect
,
You have contacted , on
Your message has been sent to the study team at ,
A copy of the message has been sent to your email
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
